Table 2

Three-year outcome for patients with rheumatoid arthritis with persistent moderate disease activity (group 1) and sustained DAS28 remission (group 2) during the first year of follow-up

Outcome variableGroup 1
Group 2
p Value
ΔmTSS from day 0*10.8±6.56.5±8.90.006
DAS28 remission (%)27.481.0<0.0001
SDAI remission (%)13.856.0<0.0001
ACR/EULAR remission‡ (%)10.350.4<0.0001
HAQ–DI <0.5 (%)43.7%80.6<0.0001
Missed workdays§157.3±226.230.9±75.90.001
Missed workdays=0¶ (%)51.467.70.007
  • Data are mean±SD unless indicated.

  • *Change in mTSS from day 0; †change in mTSS≥5 from day 0; ‡Boolean definition; §mean missed workdays since baseline; ¶percentage of patients without any missed workdays during follow-up.

  • ACR/EULAR, American College of Rheumatology/European League Against Rheumatism; DAS28, Disease Activity Score in 28 joints; HAQ-DI, Health Assessment Questionnaire-Disability Index; mTSS, van der Heijde modified total Sharp score; SDAI, Simplified Disease Activity Index.